As a reaction to elevated plasma triglycerides (TGs) and liver steatosis, hepatic miR-27b was significantly increased, and the ANGPTL3 and GPAM protein, being targets of miR-27b, were significantly repressed [47]. The gene discussed is GPAM; the disease is Hepatic steatosis.